SHAFF ERIC D. (See Remarks) sold 1.4% of their position (2.50K shares) of SERES THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/19/2024ACC: 0000950170-24-128609
Officer· See Remarks
Since Jan 2019
-2.50K
Net shares
Net seller
$1.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
7.81K acquired · 10.32K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.81K
Price / share
—
Trade value
—
% of position
4.7%
11/15/2024
165.08K→172.89K
Common Stock
Direct
Shares
−2.50K
Price / share
$0.54
Trade value
$1.35K
% of position
1.4%
11/18/2024
172.89K→170.39K
Total
Net shares
+5.31K
Net value
-$1.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/15/2024 | M · Option Exercise | +7.81K | — | — | 4.7% | 165.08K | 172.89K |
| Common Stock Direct | 11/18/2024 | S · Sale | −2.50K | $0.54 | $1.35K | 1.4% | 172.89K | 170.39K |
| Total | +5.31K | -$1.35K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
7.81K shares
Shares
−7.81K
Strike price
Held after
70.31K
Exercisable
—
11/15/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock7.81K shares | 11/15/2024 | M · Option Exercise | −7.81K | — | 70.31K |